rs150415429

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_016122.3(CEP83):​c.1565T>G​(p.Leu522Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000238 in 1,613,174 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L522L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 1 hom. )

Consequence

CEP83
NM_016122.3 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 2.00

Publications

0 publications found
Variant links:
Genes affected
CEP83 (HGNC:17966): (centrosomal protein 83) The protein encoded by this gene is a centriolar protein involved in primary cilium assembly. Defects in this gene have been associated with infantile nephronophthisis and intellectual disability. [provided by RefSeq, Oct 2016]
CEP83 Gene-Disease associations (from GenCC):
  • nephronophthisis 18
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
  • nephronophthisis 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007227689).
BP6
Variant 12-94333494-A-C is Benign according to our data. Variant chr12-94333494-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 541796.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0012 (182/152278) while in subpopulation AFR AF = 0.00431 (179/41564). AF 95% confidence interval is 0.00379. There are 0 homozygotes in GnomAd4. There are 92 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP83NM_016122.3 linkc.1565T>G p.Leu522Arg missense_variant Exon 13 of 17 ENST00000397809.10 NP_057206.2 Q9Y592-1Q3B787

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP83ENST00000397809.10 linkc.1565T>G p.Leu522Arg missense_variant Exon 13 of 17 1 NM_016122.3 ENSP00000380911.4 Q9Y592-1
CEP83ENST00000339839.9 linkc.1565T>G p.Leu522Arg missense_variant Exon 12 of 16 1 ENSP00000344655.5 Q9Y592-1
CEP83ENST00000547232.5 linkn.1466T>G non_coding_transcript_exon_variant Exon 13 of 17 1 ENSP00000447783.1 A0A338VFC5
CEP83ENST00000546587.1 linkn.441T>G non_coding_transcript_exon_variant Exon 2 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.00119
AC:
181
AN:
152160
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00430
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000342
AC:
85
AN:
248758
AF XY:
0.000245
show subpopulations
Gnomad AFR exome
AF:
0.00524
Gnomad AMR exome
AF:
0.0000582
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000332
GnomAD4 exome
AF:
0.000138
AC:
202
AN:
1460896
Hom.:
1
Cov.:
31
AF XY:
0.000111
AC XY:
81
AN XY:
726696
show subpopulations
African (AFR)
AF:
0.00524
AC:
175
AN:
33412
American (AMR)
AF:
0.000269
AC:
12
AN:
44574
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39664
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
85964
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53382
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1111646
Other (OTH)
AF:
0.000199
AC:
12
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00120
AC:
182
AN:
152278
Hom.:
0
Cov.:
32
AF XY:
0.00124
AC XY:
92
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00431
AC:
179
AN:
41564
American (AMR)
AF:
0.000131
AC:
2
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68000
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000591
Hom.:
3
Bravo
AF:
0.00144
ESP6500AA
AF:
0.00712
AC:
26
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000464
AC:
56
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Feb 14, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

CEP83-related disorder Benign:1
Mar 16, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Nephronophthisis 18 Benign:1
Dec 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
18
DANN
Benign
0.23
DEOGEN2
Benign
0.021
.;.;T
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.41
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Benign
0.69
.;T;T
M_CAP
Benign
0.0076
T
MetaRNN
Benign
0.0072
T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
2.0
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.040
N;N;.
REVEL
Benign
0.043
Sift
Benign
0.82
T;T;.
Sift4G
Benign
0.74
T;T;T
Vest4
0.43
MVP
0.27
MPC
0.12
ClinPred
0.0052
T
GERP RS
3.5
Varity_R
0.14
gMVP
0.18
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150415429; hg19: chr12-94727270; API